Literature DB >> 20164231

Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses.

Yoichi Furuya1, Jennifer Chan, Matthias Regner, Mario Lobigs, Aulikki Koskinen, Tuckweng Kok, Jim Manavis, Peng Li, Arno Müllbacher, Mohammed Alsharifi.   

Abstract

We previously demonstrated that a single dose of nonadjuvanted intranasal gamma-irradiated influenza A virus can provide robust protection in mice against both homologous and heterosubtypic challenges, including challenge with an H5N1 avian virus strain. We investigated the mechanism behind the observed cross-protection to define which arms of the adaptive immune response are involved in mediating this protection. Studies with gene knockout mice showed the cross-protective immunity to be mediated mainly by T cells and to be dependent on the cytolytic effector molecule perforin. Adoptive transfer of memory T cells from immunized mice, but not of memory B cells, protected naïve recipients against lethal heterosubtypic influenza virus challenge. Furthermore, gamma-irradiated influenza viruses induced cross-reactive Tc-cell responses but not cross-neutralizing or cross-protective antibodies. In addition, histological analysis showed reduced lung inflammation in vaccinated mice compared to that in unvaccinated controls following heterosubtypic challenge. This reduced inflammation was associated with enhanced early recruitment of T cells, both CD4(+) and CD8(+), and with early influenza virus-specific cytotoxic T-cell responses. Therefore, cross-protective immunity induced by vaccination with gamma-irradiated influenza A virus is mediated mainly by Tc-cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164231      PMCID: PMC2863765          DOI: 10.1128/JVI.02508-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.

Authors:  J B Ulmer; T M Fu; R R Deck; A Friedman; L Guan; C DeWitt; X Liu; S Wang; M A Liu; J J Donnelly; M J Caulfield
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

2.  Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.

Authors:  S L Epstein; C Y Lo; J A Misplon; C M Lawson; B A Hendrickson; E E Max; K Subbarao
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

3.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.

Authors:  D Kägi; B Ledermann; K Bürki; P Seiler; B Odermatt; K J Olsen; E R Podack; R M Zinkernagel; H Hengartner
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

4.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.

Authors:  M B Mazanec; C L Coudret; D R Fletcher
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

5.  Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.

Authors:  S Liang; K Mozdzanowska; G Palladino; W Gerhard
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

6.  Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes.

Authors:  H H Nguyen; H L Vu; J R McGhee; J Mestecky
Journal:  J Infect Dis       Date:  2000-12-20       Impact factor: 5.226

7.  Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.

Authors:  S Tamura; Y Ito; H Asanuma; Y Hirabayashi; Y Suzuki; T Nagamine; C Aizawa; T Kurata
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

8.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.

Authors:  V A Slepushkin; J M Katz; R A Black; W C Gamble; P A Rota; N J Cox
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

10.  Human cytotoxic T-lymphocyte repertoire to influenza A viruses.

Authors:  J Jameson; J Cruz; F A Ennis
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more
  41 in total

1.  Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.

Authors:  Megan K L MacLeod; Amy S McKee; Alexandria David; Jieru Wang; Robert Mason; John W Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 2.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

3.  Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.

Authors:  Grace L Chen; Yuk-Fai Lau; Elaine W Lamirande; Amber W McCall; Kanta Subbarao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-03       Impact factor: 11.205

4.  T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model.

Authors:  Hailong Guo; Félix Santiago; Kris Lambert; Toru Takimoto; David J Topham
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

5.  Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection.

Authors:  Shigefumi Okamoto; Sumiko Matsuoka; Nobuyuki Takenaka; Ahmad M Haredy; Takeshi Tanimoto; Yasuyuki Gomi; Toyokazu Ishikawa; Takami Akagi; Mitsuru Akashi; Yoshinobu Okuno; Yasuko Mori; Koichi Yamanishi
Journal:  Clin Vaccine Immunol       Date:  2012-05-02

6.  Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.

Authors:  Timothy J Powell; Jonathan D Silk; Jane Sharps; Ervin Fodor; Alain R M Townsend
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

7.  CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.

Authors:  Kristin Scheible; Gang Zhang; Jane Baer; Mitra Azadniv; Kris Lambert; Gloria Pryhuber; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

8.  Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.

Authors:  Meito Shibuya; Taiki Aoshi; Etsushi Kuroda; Yasuo Yoshioka
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

9.  Asthma increases susceptibility to heterologous but not homologous secondary influenza.

Authors:  Yoichi Furuya; Sean Roberts; Gregory J Hurteau; Alan M Sanfilippo; Rachael Racine; Dennis W Metzger
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

10.  Repeated Antigen Exposure Extends the Durability of Influenza-Specific Lung-Resident Memory CD8+ T Cells and Heterosubtypic Immunity.

Authors:  Natalija Van Braeckel-Budimir; Steven M Varga; Vladimir P Badovinac; John T Harty
Journal:  Cell Rep       Date:  2018-09-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.